301331.SZ · 恩威医药
China A-shares · RS rating 45 · As of 2026-10-14
| Price | 21.05 CNY |
|---|---|
| 1-day change | -2.3% |
| RS rating (overall / 1M / 3M / 12M) | 45 / 63 / 65 / 15 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 9 / 6 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +13.6% |
| Distance from 52-week high | +36.8% |
| Market cap (USD) | $340.4M |